TY - JOUR
T1 - Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful?
AU - Massaccesi, Mariangela
AU - Digesu', Cinzia
AU - Macchia, Gabriella
AU - Deodato, Francesco
AU - Ciuffreda, Marcello
AU - Cucci, Eleonora
AU - Caravatta, Luciana
AU - Corrado, Giacomo
AU - Padula, G. D.A.
AU - De Vizia, R.
AU - De Vizia, Roberta
AU - Cellini, Numa
AU - Valentini, Vincenzo
AU - Sallustio, Giuseppina
AU - Ferrandina, Maria Gabriella
AU - Pacelli, Fabio
AU - Morganti, Alessio Giuseppe
PY - 2012
Y1 - 2012
N2 - Objective: The aim of this study was to evaluate the role of bilateral mammography undertaken before adjuvant radiotherapy in patients with conservatively managed invasive carcinoma of the breast.Methods: Patients with invasive breast cancer referred to the Radiotherapy Department of the Catholic University in Campobasso, Italy, between March 2002 and September 2006 were retrospectively reviewed. Patients were referred to our facility from other local and regional hospitals where they received breast-conserving surgery and adjuvant chemotherapy. They presented to our department for post-operative whole-breast radiotherapy. All patients underwent physical examination and bilateral mammography prior to adjuvant irradiation.Results: 201 patients met the selection criteria as delineated. Of these 201 patients who underwent pre-radiotherapy mammography, 3 had suspicious findings on mammography. In 2 of those cases, the histopathological examination confirmed the presence of residual disease within the residual mammary gland. In one case, the pre-radiotherapy mammogram allowed for the detection of disease persistence which was not otherwise appreciated on physical exam. In the other case, the diagnostic imaging confirmed only the findings of the physical exam. In both cases of residual disease, the tumour was found elsewhere in the breast and not at the primary site. In one patient, the radiological re-assessment led to a false-positive result. No cases of contralateral synchronous breast cancer were observed. The overall adjunctive cost of this strategy including a routine mammography besides the clinical visit was €7012 for all patients.Conclusions: No clear recommendation exists regarding post-operative mammography before adjuvant radiotherapy. In our experience, this strategy allowed for the detection of gross disease persistence after surgery which was not appreciated at clinical examination in 1 case out of 201. In this patient, adjuvant radiotherapy up to a total dose of 50 Gy would have been inadequate. Given the low cost of mammography, further investigation about its role in pre-radiotherapy evaluation are warranted.
AB - Objective: The aim of this study was to evaluate the role of bilateral mammography undertaken before adjuvant radiotherapy in patients with conservatively managed invasive carcinoma of the breast.Methods: Patients with invasive breast cancer referred to the Radiotherapy Department of the Catholic University in Campobasso, Italy, between March 2002 and September 2006 were retrospectively reviewed. Patients were referred to our facility from other local and regional hospitals where they received breast-conserving surgery and adjuvant chemotherapy. They presented to our department for post-operative whole-breast radiotherapy. All patients underwent physical examination and bilateral mammography prior to adjuvant irradiation.Results: 201 patients met the selection criteria as delineated. Of these 201 patients who underwent pre-radiotherapy mammography, 3 had suspicious findings on mammography. In 2 of those cases, the histopathological examination confirmed the presence of residual disease within the residual mammary gland. In one case, the pre-radiotherapy mammogram allowed for the detection of disease persistence which was not otherwise appreciated on physical exam. In the other case, the diagnostic imaging confirmed only the findings of the physical exam. In both cases of residual disease, the tumour was found elsewhere in the breast and not at the primary site. In one patient, the radiological re-assessment led to a false-positive result. No cases of contralateral synchronous breast cancer were observed. The overall adjunctive cost of this strategy including a routine mammography besides the clinical visit was €7012 for all patients.Conclusions: No clear recommendation exists regarding post-operative mammography before adjuvant radiotherapy. In our experience, this strategy allowed for the detection of gross disease persistence after surgery which was not appreciated at clinical examination in 1 case out of 201. In this patient, adjuvant radiotherapy up to a total dose of 50 Gy would have been inadequate. Given the low cost of mammography, further investigation about its role in pre-radiotherapy evaluation are warranted.
KW - BREAST CANCER
KW - BREAST CANCER
UR - http://hdl.handle.net/10807/32862
U2 - 10.1259/bjr/16600336
DO - 10.1259/bjr/16600336
M3 - Article
SN - 0007-1285
VL - 85 (1017)
SP - 682
EP - 685
JO - British Journal of Radiology
JF - British Journal of Radiology
ER -